HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
DAIC
MARCH 27, 2024
mtaschetta-millane Wed, 03/27/2024 - 08:08 March 27 2024 — HeartFlow, Inc. , HeartFlow Plaque Analysis is the only FDA cleared AI-enabled plaque quantification tool validated in a prospective international trial against the gold standard of invasive imaging (IVUS), with a reported 95% agreement.
Let's personalize your content